Submitted by Anonymous (not verified) on 27 June 2025 - 14:55
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 37, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 37, Status: Authorised